Skip to main content

A case of metastatic breast carcinoma to the skin expressing SARS-CoV-2 spike protein possibly derived from mRNA vaccine

Journal: Journal of Dermatological Science
Lead Author: Shigetoshi Sano
Original date of publication: 10/03/2025
Link: https://www.jdsjournal.com/article/S0923-1811(25)00180-X/abstract#supplementary-materiall

Summary Context

This study found a woman whose cancer was in remission but after her sixth mRNA shot, spike protein was found in her carcinoma.

Comments

This article is copyrighted by Health Freedom Defense Fund, Inc.
Visit our Re-post guidelines

This study used genetic testing of a carcinoma (tumor) and found what appeared to be vaccine-specific genetic fragments (no necleocapsid) of the spike protein. This patient had 6 mRNA injections.

Abstract or Results, Key Passages

From a third party review by Hulscher as the original is behind paywall, on potential implications: “Genomic integration of vaccine-derived mRNA or contaminant DNA fragments in host cells.Immune tolerance induction via spike-driven PD-L1 upregulation and Type I interferon suppression, impairing anti-tumor immunity.Estrogen receptor modulation by spike protein, potentially accelerating breast and ovarian cancer proliferation.

Keywords: Metastatic skin cancerBreast carcinomaPagetoid cellSARS-CoV-2 spike proteinmRNA vaccine
Full Author List: Shigetoshi Sano